
Sign up to save your podcasts
Or


Dr. Jeff Ratliff talks with Drs. Howard Colman and Kelly Fritz about the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage.
By American Academy of Neurology4.7
285285 ratings
Dr. Jeff Ratliff talks with Drs. Howard Colman and Kelly Fritz about the availability of lomustine for the treatment of glioblastoma multiforme (GBM) in light of the drug's recent withdrawal from Medicare Part D coverage.

319 Listeners

496 Listeners

50 Listeners

3,343 Listeners

12 Listeners

1,147 Listeners

23 Listeners

193 Listeners

513 Listeners

134 Listeners

369 Listeners

189 Listeners

373 Listeners

316 Listeners

82 Listeners